Emergent Biosolutions reported $111.5M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Akebia Therapeutics AKBA:US $ 40.95M 32.42M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amarin AMRN:US $ 111.83M 10.51M
Ani Pharmaceuticals ANIP:US $ 27.65M 1.34M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Coherus Biosciences CHRS:US $ 61.22M 9.72M
Emergent Biosolutions EBS:US $ 111.5M 58.2M
Exact Sciences EXAS:US $ 340.64M 19.79M
Exelixis EXEL:US $ 316.55M 53.74M
Flexion Therapeutics FLXN:US $ 17.6M 5.6M
Glaxosmithkline GSK:US $ 6255M 682M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Ironwood Pharmaceuticals IRWD:US $ 103.75M 0.28M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Lexicon Pharmaceuticals LXRX:US 23K 211K
Lonza Group LONN:SW 1.04B 418M
Merk MRK:US $ 10098M 1738M
Moderna Inc MRNA:US 4.25B 643M
Myriad Genetics MYGN:US $ 119.5M 16.2M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Opko Health OPK:US $ 141.86M 7.64M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Pfizer PFE:US $ 14163M 2178M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Seattle Genetics SGEN:US $ 341.41M 31.02M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M
United Therapeutics UTHR:US $ 417M 7.7M
Vanda Pharmaceuticals VNDA:US $ 63.3M 1.96M